BBG Advanced Therapies shared a post on LinkedIn:
“We’re proud to announce a collaboration between BBG Advanced Therapies and Kite Pharma, a Gilead Company, on an initiative designed to expand access to CAR T-cell therapy— bringing the starting point of these life-saving treatments closer to patients, and communities all across Texas.
Across a state as large and diverse as Texas, this will help reduce barriers, expand access, and accelerate the path to life-saving therapy.
And it’s only the beginning.
This will serve as a blueprint for expanding access nationwide, helping ensure more patients—no matter where they live in Texas—can benefit from the option of CAR T-cell therapy.
We’re honored to lead this work. And even more excited for what comes next.